5 from QS/1: Highlights in Pharmacy News – May 2019

QPath Blog Logo

Check out 4 developments in our field that are worth knowing about – and 1 extra, just because.

  1. FDA Patient Education Campaign Targets Opioid Diversion, Disposal

The FDA has launched a public awareness program called Remove the Risk. The agency contends that “if every household removed prescription opioids once they’re no longer medically needed… it would have a major impact on the opioid crisis.”

  1. FTC Charges Surescripts with Illegal Monopolization of E-Prescription Markets

The federal agency is suing the company for anticompetitive restraints that monopolize routing and eligibility services in the electronic prescribing market.

  1. NCPA, NACDS Statement on Drug Pricing Rule’s Failure to Reform Pharmacy DIR

After a final drug pricing rule failed to reform DIR fees, the National Community Pharmacists Association and the National Association of Chain Drug Stores expressed disappointment and frustration, warning  of the unsustainable situation faced by pharmacies.

  1. USP Compounding Updates Nearing Publication, Implementation

Chapters that contain revised standards for sterile and non-sterile compounding, as well as for radiopharmaceuticals, will be published June 1 for implementation by December 1.

Just because…
5. Facebook Takes Steps to Reduce Vaccine Misinformation

The company announced that groups or pages that post inaccurate information about vaccines will see their rankings reduced in the news feed and search results.

Share this Post

Comments (0)